Allergan (AGN) Declares $0.74 Quarterly Dividend; 1.6% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Ironwood Pharma (IRWD), Allergan (AGN) Settle LINZESS (linaclotide) Patent Litigation with Teva (TEVA)
January 22, 2020 9:21 AM ESTIronwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the companies have reached an agreement with Teva Pharmaceuticals, USA (NYSE: TEVA) resolving patent litigation brought in response to Tevas abbreviated new drug application (ANDA) seeking approval to market generic versions of 145 mcg and 290 mcg LINZESS (linaclotide) prior to the expiration of the companies applicable patents. This settlement with Teva is the last of the remaining defendants in this patent... More
Wells Fargo Downgrades Allergen (AGN) to Equal Weight
January 22, 2020 4:29 AM ESTWells Fargo analyst David Maris downgraded Allergen (NYSE: AGN) from Overweight to Equal Weight with a price target of $198.00.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $192.58 yesterday.
... More